TITLE

Automated DNA mutation detection using universal conditions direct sequencing: application to ten muscular dystrophy genes

PUB. DATE
January 2009
SOURCE
BMC Genetics;2009, Vol. 10, p66
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
47213949

 

Related Articles

  • Rapid direct sequence analysis of the three genes encoding collagen VI. Lampe, Anne Katrin; Dunn, D.M.; von Niderhausen, A.C.; Aoyagi, A.; Hamil, C.; Duval, B.; O'Brien, K.; Laval, S.; Chu, M.L.; Swoboda, K.; Muntoni, F.; Bonnemann, C.; Flanigan, K.M.; Bushby, K.; Weiss, R.B. // Journal of Medical Genetics;Sep2003 Supplement, Vol. 40, pS65 

    Mutations in any of the three collagen 6A genes (COL6A1, COL6A2, and COL6A3) are responsible for Bethlem myopathy (BM) and Ullrich's congenital muscular dystrophy (UCMD). Diagnostic DNA testing in these conditions is difficult because of the large size of the genes involved and the frequent...

  • A novel mutation in KRT12 associated with Meesmann’s epithelial corneal dystrophy. Irvine, A. D.; Coleman, C. M.; Moore, J. E.; Swensson, O.; Morgan, S. J.; McCarthy, J. H.; Smith, F. J. D.; Black, G. C. M.; McLean, W. H. I. // British Journal of Ophthalmology;Jul2002, Vol. 86 Issue 7, p729 

    Background: The molecular basis of Meesmann’s epithelial corneal dystrophy (MECD) has recently been attributed to mutations in the cornea specific keratin genes KRT3 and KRT12. The mechanisms by which these mutations cause the Meesmann’s phenotype are not clear. This study presents...

  • Puny proteins predict breast cancer risk. Berger, Abi // New Scientist;6/10/95, Vol. 146 Issue 1981, p16 

    Reports on Frans Hogervorst and colleagues at the University of Leiden in Holland's development of screening tests to detect the gene, BRCA1, which is responsible for half of all inherited breast tumors. Prior use of the tests in detecting Duchenne muscular dystrophy causing genes; Polymerase...

  • Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy. Taylor, Peter J.; Maroulis, Sarah; Mullan, Glenda L.; Pedersen, Robyn L.; Baumli, Aurora; Elakis, George; Piras, Sara; Walsh, Corrina; Próper-Gutiérez, Benito; De La Puente-Alonso, Fernancdo; Bell, Christopher G.; Mowat, David R.; Johnston, Heather M.; Buckley, Michael F. // Journal of Medical Genetics;Jun2007, Vol. 44 Issue 6, p368 

    Background: Recent methodological advances have improved the detection rate for dystrophin mutations, but there are no published studies that have measured the clinical utility of these protocols for carrier detection compared with conventional carrier testing protocols that use pedigree, serum...

  • Preclinical Studies for Gene Therapy of Duchenne Muscular Dystrophy. Odom, Guy L.; Banks, Glen B.; Schultz, Brian R.; Gregorevic, Paul; Chamberlain, Jeffrey S. // Journal of Child Neurology;Sep2010, Vol. 25 Issue 9, p1149 

    The muscular dystrophies are a diverse group of genetic disorders without an effective treatment. Because they are caused by mutations in various genes, the most direct way to treat them involves correcting the underlying gene defect (ie, gene therapy). Such a gene therapy approach involves...

  • Isolating the gene for Duchenne muscular dystrophy. Harper, Peter S. // British Medical Journal (Clinical Research Edition);9/27/1986, Vol. 293 Issue 6550, p773 

    Examines the isolation of genes for Duchenne muscular dystrophy. DNA techniques in the identification of a gene; Variations in DNA sequence; Combination of DNA analysis with the approach of creatine kinase testing.

  • Pathology: Two of a kind. Atkinson, Sophie // Nature Reviews Cancer;Jun2011, Vol. 11 Issue 6, p390 

    The article discusses research being done on muscular dystrophies. It references the study "DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in Muscular Dystrophies" by W. M. Schmidt and colleagues in the 2011 issue. Commonly mutated muscular dystrophy-associated genes such...

  • DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations. Juan-Mateu, Jonas; Gonzalez-Quereda, Lidia; Rodriguez, Maria Jose; Baena, Manel; Verdura, Edgard; Nascimento, Andres; Ortez, Carlos; Baiget, Montserrat; Gallano, Pia // PLoS ONE;8/18/2015, Vol. 10 Issue 8, p1 

    Recent advances in molecular therapies for Duchenne muscular dystrophy (DMD) require precise genetic diagnosis because most therapeutic strategies are mutation-specific. To understand more about the genotype-phenotype correlations of the DMD gene we performed a comprehensive analysis of the DMD...

  • A Streamlined Protocol for Molecular Testing of the DMD Gene within a Diagnostic Laboratory: A Combination of Array Comparative Genomic Hybridization and Bidirectional Sequence Analysis. Marquis-Nicholson, Renate; Lai, Daniel; Chuan-Ching Lan; Love, Jennifer M.; Love, Donald R. // ISRN Neurology;2013, p1 

    Purpose. The aim of this study was to develop a streamlined mutation screening protocol for the DMD gene in order to confirm a clinical diagnosis of Duchenne or Becker muscular dystrophy in affected males and to clarify the carrier status of female family members. Methods. Sequence analysis and...

  • CHALLENGES TO GENE THERAPY FOR DUCHENNE MUSCLE DYSTROPHY. Gronek, Piotr; Rychlewski, Tadeusz; Lehmann, Joanna; Celichowski, Jan; Lipiński, Daniel; Szlata, Marlena; Lassociński, Wojciech; Słomski, Ryszard // Studies in Physical Culture & Tourism;2006, Vol. 13 Issue 1, p9 

    Muscular myopathies are a heterogeneous group of disorders caused by a number of factors. Many muscular myopathies are of genetic origin, especially muscular dystrophies (MDs) caused by mutations in any of the large num-ber of genes (Emery 2002). Duchenne and Becker muscular dystrophies are...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics